Daptomycin Nge Cas 103060-53-3 99% Ubunyulu
I-Datomicin sisibulali-zintsholongwane esitsha esakhiweyo se-cyclic lipopeptide ekhutshwa kumhluzi wokubilisa we-Streptomyces. Ukongeza ekusebenzeni kwiibhaktheriya ezininzi zegram-positive, kubaluleke kakhulu ukuba inomsebenzi oqinileyo kwi-vitro ngokuchasene neentlobo ezizimeleyo ezibonise ukuxhathisa i-methicillin, i-vancomycin kunye ne-linezolidine, olu phawu lubaluleke kakhulu ukubaluleka kwekliniki kwizigulana ezosulelekileyo.
Igama lemveliso: | Daptomycin | Inombolo yeqela. | JL20220811 |
Cas | 103060-53-3 | MF Umhla | Agasti 11, 2022 |
Ukupakisha | 1KG/BAG | Umhla wohlalutyo | Agasti 11, 2022 |
Ubungakanani | 100KGS | Umhla WOKUPHELELWA | Agasti 10, 2024 |
ITEM | SI-TANDARD | IZIPHUMO | |
Imbonakalo | Umthubi okhanyayo ukuya kumgubo omthubi | Vumelana | |
Ivumba | Ayinavumba | Vumelana | |
Isivavanyi | ≥95.0% | 97.9% | |
I-optical ethileukujikeleza | +15.5+20.5 | +16,8 | |
Ukucaca kwesisombululo | Icacisiwe | Icacisiwe | |
PH | 3.0-4.5 | 3.2 | |
Intsalela ekutshisweni | ≤0.2% | 0.1% | |
Amanzi | ≤5.0% | 2.4% | |
ILactone hydrolyzate | ≤0.80% | 0.08% | |
i-β-isomere | ≤1.5% | 0.1% | |
RS-5/6 | ≤0.80% | 0.06% | |
RS-7 | ≤0.80% | Ayifunyaniswanga | |
RS-7a/7b | ≤0.20% | 0.07% | |
I-Anhydrodaptomycin | ≤2.0% | 0.8% | |
Omnye umntu | ≤0.15% | Ayifunyaniswanga | |
Ukungcola okupheleleyo | ≤5.0% | 1.1% | |
Ethyl utywala | ≤0.5% | 0.0% | |
Acetic acid | ≤0.5% | Ayifunyaniswanga | |
I-endotoxin yebhaktheriya(EU/mg) | ≤0.28 | <0.28 | |
Iibhaktheriya zeAerobic(cfu/g) | ≤1000 | <10 | |
Umngundo & negwele(cfu/g) | ≤100 | <10 | |
E.coil | Ayifunyaniswanga | Ayifunyaniswanga | |
Ukuqukumbela | Ufanelekile |
Unyango oluphakathi kunyango lwezifo zesikhumba kunye nesakhiwo solusu ezibangelwa ngamanye ama-gram-positive kunye neentlobo ezinovakalelo.
Ibhegi ye-1kgs okanye imfuno yabathengi. Yigcine kude nokukhanya kubushushu obungaphantsi kwe 25℃.
I-Daptomycin Nge-Cas 103060-53-3